Ayala Pharmaceuticals Inc (ADXS)

[exel_mm]

"the one million increase in short interest means Astra dumped ADXS" could not be further from the truth. In fact, short players on biotechs do not do exhaustive FA, but rather simply focus on TA. Furthermore, we are talking biotechs here, so essentially Advaxis is simply one in the pool of many being traded, etc.

Bottom line, the game is being played and continues to be played. Shorts, however, are playing a very, very dangerous game because ADXS is going to be the one of twenty that breaks the mold.

In short, the shorts will get burned. Inevitable.